Price
Frequently asked questions
What is IQVIA Hldgs's market capitalization?
What is IQVIA Hldgs's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for IQVIA Hldgs?
What are the analyst ratings and target price for IQVIA Hldgs's stock?
What is IQVIA Hldgs's revenue over the trailing twelve months?
What is the EBITDA for IQVIA Hldgs?
What is the free cash flow of IQVIA Hldgs?
What is the 5-year beta of IQVIA Hldgs's stock?
How many employees does IQVIA Hldgs have, and what sector and industry does it belong to?
What is the free float of IQVIA Hldgs's shares?
Financials
Market Cap
$35.86B5Y beta
1.50EPS (TTM)
$7.622Free Float
179.82MP/E ratio (TTM)
25.93Revenue (TTM)
$15.32BEBITDA (TTM)
$3.29BFree Cashflow (TTM)
$1.96BPricing
Analyst Ratings
The price target is $267.61 and the stock is covered by 22 analysts.
Buy
18
Hold
4
Sell
0
Information
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.
88,000
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker